SEARCH RESULTS FOR: "Tag: CBAY"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(1)
2018(1)
2017(1)
2015(1)
CATEGORIES
Analyst Update(1)
Buzz Stocks(2)
General(1)

6/11/2019 9:39 AM
The shares of Cymabay Therapeutics Inc (NASDAQ:CBAY) are plummeting, after its experimental drug used to treat a fatty liver disease called nonalcoholic steatohepatitis (NASH) was only minimally effec...
4/11/2018 10:05 AM
Two biotech stocks are making big moves higher this morning, defying the broad-market headwinds related to geopolitical tensions in Syria. Inovio Pharmaceuticals Inc (NASDAQ:INO) scored a critical p...
11/28/2017 9:52 AM
Analysts are weighing in drug stocks Intercept Pharmaceuticals Inc (NASDAQ:ICPT), Biogen Inc (NASDAQ:BIIB), and Regeneron Pharmaceuticals Inc (NASDAQ:REGN). Here's a quick roundup of today's beari...
2/24/2015 9:28 AM
U.S. benchmarks are hovering around breakeven before the opening bell, with investors looking forward to Fed Chair Janet Yellen's two-day testimony before Congress. Among the equities in focus are dr...
PEOPLE ALSO SEARCH FOR

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center